Singapore markets open in 1 hour 12 minutes

Straits Times Index
3,187.66
+32.97(+1.05%)
S&P 500
5,011.12
-11.09(-0.22%)
Dow
37,775.38
+22.07(+0.06%)
Nasdaq
15,601.50
-81.87(-0.52%)
Bitcoin USD
63,466.25
+2,128.52(+3.47%)
CMC Crypto 200
1,312.03
+426.49(+48.16%)

Clinuvel Pharmaceuticals Limited (CUV.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

15.29

+0.14

(+0.92%)

At close: 04:10PM AEST

All

Simply Wall St.
Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Clinuvel Pharmaceuticals' (ASX:CUV) stock is up by a considerable 8.7% over the past month. Since the market usually...
GlobeNewswire
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® (afamelanotide) and the future of photomedicine. Over 70 guests discussed the Company’s unique history and future growth potential at an invitation-only event in Düsseldorf. Managing Director and CEO, Dr Philippe Wolgen shared the Company’s success in establishing profitability over the past seven financial years
Simply Wall St.
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Clinuvel Pharmaceuticals...